Your institution may have access to this item. Find your institution then sign in to continue.
Title
Mometasone furoate/ formoterol fuma rate: withdrawal of marketing authorization application.
Abstract
The article reports on a 2010 decision which the manufacturer of the combination drug mometasone furoate/formoterol fumarate made to notify the European Medicines Agency about its decision to withdraw the application for a centralized marketing authorization for the drug.